Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering By Investing.com

Published on 12 Apr 2024 on Investing.com

Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the pricing of its upsized underwritten...

Read the rest of the article

Start tracking your investments with Statfolio

On Monday, Cathie Wood-led Ark Invest made significant trades, with the most notable being the tr...

Benzinga 5 Nov 2024

SAN FRANCISCO—Hans van Houte, Chief Financial Officer of Nurix Therapeutics, Inc. (NASDAQ:NRIX),...

Investing.com 31 Oct 2024

SAN FRANCISCO—Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NASDAQ:NRIX),...

Investing.com 31 Oct 2024

Key Insights Significantly high institutional ownership implies Nurix Therapeutics' stock price i...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

On June 20, 2024, Houte Van, Chief Financial Officer of Nurix Therapeutics Inc (NASDAQ:NRIX), exe...

GuruFocus.com · via Yahoo Finance 20 Jun 2024

Roche Holding AG RHHBY announced that the late-stage study evaluating its marketed drug, Columvi ...

Zacks via Yahoo Finance 15 Apr 2024

Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the pricing of its upsized underwritten...

Investing.com 12 Apr 2024

Nurix Therapeutics, Inc. ( Nasdaq : NRIX) today announced the pricing of its upsized underwritten...

Investing.com 12 Apr 2024

ALX Oncology Holdings Inc. ALXO reported positive results from an ongoing phase I/II investigator...

Zacks via Yahoo Finance 11 Apr 2024

On Thursday, RBC Capital increased its share price target on Nurix Therapeutics Inc. (NASDAQ:NRIX...

Investing.com 11 Apr 2024